The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line (1L) divarasib plus pembrolizumab (pembro) in advanced or metastatic KRAS G12C+ non–small cell lung cancer (NSCLC): Results from the Krascendo-170 study.
 
Ferdinandos Skoulidis
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics
Honoraria - Curio Science; DAVA Oncology; ESMO; IDEOlogy Health; Intellisphere; Intellisphere; Japanese Lung Cancer Society; McGill Universite de Montreal; Medscape; MJH Life Sciences; Moving Innovation and Technology; PER; Physicans' Education Resource; RV Mais
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; BergenBio; Bridgebio; Bristol Myers Squibb Foundation; Calithera Biosciences; Genmab; Guardant Health; Hookipa Pharma; Intellisphere; Lilly; Lilly; Medscape; Merck; Navire; Novartis; Novocure; Regeneron; Revolution Medicines; Roche/Genentech; Tango Therapeutics
Research Funding - AIMM Therapeutics (I); Amgen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Revolution Medicines (Inst)
Travel, Accommodations, Expenses - American Association for Cancer Research; Curio Science; Dava Oncology; IASLC; IDEOlogy Health; MI&T; MJH Life Sciences; PER
 
Kristof Cuppens
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; ITeos Therapeutics; Janssen; MSD; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst)
Expert Testimony - Abbvie; AstraZeneca; MSD; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Janssen; MSD; Roche/Genentech
 
Willemijn Theelen
Consulting or Advisory Role - AstraZeneca (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); MSD (Inst); Regeneron (Inst)
 
Caicun Zhou
Leadership - IASLC BOD
Honoraria - Akeso Biopharma; Alice; Amoy Diagnostics; Anheart Therapeutics; Hengrui Therapeutics; Innovent Biologics; Lilly; Luye Pharma; Merck Sharpe and Dohme; MSD; QiLu Pharmaceutical; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Amoy Diagnostics; Hengrui Therapeutics; Innovent Biologics; QiLu Pharmaceutical; Top Alliance BioScience
 
Enriqueta Felip
Honoraria - Amgen; Daiichi Sankyo Europe GmbH; Gilead Sciences; Janssen / Johnson & Johnson; Lilly; MSD; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; Genentech/Roche; GlaxoSmithKline; ITeos Therapeutics; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Pfizer; PharmaMar; Pierre Fabre; Regeneron; Seagen; Tubulis GmbH
Other Relationship - GRIFOLS
(OPTIONAL) Uncompensated Relationships - "ETOP IBCSG Partners" Member of the Scientific Committee; Member of the Scientific Advisory Committee -Hospital Universitari Parc Taulí-; SEOM (Sociedad Española de Oncología Médica), President from 2021-2023
 
Jung Seop Eom
Employment - Pusan National University Hospital
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; IMBdx; Merck; MSD; Mundipharma; Novartis; Roche; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; IMBdx; MSD; Roche; Takeda; Yuhan
Research Funding - Boehringer Ingelheim; Boryung; Yuhan
 
Jennifer Friedmann
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - IQVIA
 
Gennaro Daniele
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Rajwanth Veluswamy
Consulting or Advisory Role - Archetype Therapeutics; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech; Merck; Merus; Novocure; Regeneron; Revolution Medicines; Serna Bio; Shionogi
Speakers' Bureau - Abbvie; AstraZeneca
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Tempus
 
Benjamin Solomon
Honoraria - Amgen (Inst); AstraZeneca; Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); BeiGene; Bristol-Myers Squibb (Inst); GlaxoSmithKline; GlaxoSmithKline (Inst); Johnson & Johnson/Janssen; Lilly; Merck Sharp & Dohme; Nuvalent, Inc.; Pfizer (Inst); Roche/Genentech (Inst); Takeda
Patents, Royalties, Other Intellectual Property - UpToDate
 
Teresa Moran
Consulting or Advisory Role - AstraZeneca; Roche
 
Flavio Augusto Ferreira da Silva
No Relationships to Disclose
 
Karina Vera
Employment - Hospital Britanico
Consulting or Advisory Role - Adium Pharma; Amgen; AstraZeneca; MSD; Roche
 
Mariah Clarisse Mayo
No Relationships to Disclose
 
Ahmadur Rahman
Employment - Roche
Stock and Other Ownership Interests - Merck; Roche
Travel, Accommodations, Expenses - Roche
 
Shuai Li
Employment - Genentech
 
Hen Prizant
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Genentech
Travel, Accommodations, Expenses - Genentech
 
Chipman Stroud
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Christoph Meyenberg
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Adrian Sacher
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Bridgebio (Inst); CRISPR Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Hotspot Therapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly Loxo (Inst); Merck (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech/Roche; Merck
(OPTIONAL) Uncompensated Relationships - Amgen; Genentech/Roche; Merck